RecruitingNCT06527521

Prevalence of Amyloidosis in Trauma Patients

Prevalence of Amyloidosis in Trauma Patients Using Red Flags Tool


Sponsor

Consorci Sanitari de l'Alt Penedès i Garraf

Enrollment

246 participants

Start Date

Nov 13, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

This study aims to determine the frequency of amyloidosis among patients undergoing trauma surgery.


Eligibility

Inclusion Criteria3

  • Men and women included in the waiting list for scheduled trauma surgery with at least one of the following criteria defined as red flags: Over 65 years old; Possible family history of amyloidosis, Cardiac pathology: aortic stenosis, presence of left ventricular hypertrophy defined as interventricular septal thickness > 12mm measured by echocardiography, history of previous brady- or tachyarrhythmias including cardiac conduction blocks, history of syncope or presyncope, pro BNP > 300 in previous blood tests; History of sensory peripheral neuropathy; History of nephropathy without etiological diagnosis; History of liver disease without a clear cause.
  • Ability to cooperate in the necessary evaluations.
  • Signed informed consent for inclusion in the study, either by the participant or their legal representative.

Exclusion Criteria1

  • \- Participants previously diagnosed with amyloidosis cannot be included in the study.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDURETraumatologic surgery

Patients undergoing trauma surgery


Locations(1)

Consorci Sanitari Alt Penedes i Garraf-Hospital Sant Camil

Sant Pere de Ribes, Barcelona, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06527521


Related Trials